Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
70 hedge funds and large institutions have $57.5M invested in Histogen Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 6 closing their positions.
450% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 6
120% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 10
84% more capital invested
Capital invested by funds: $31.3M → $57.5M (+$26.2M)
63% more funds holding
Funds holding: 43 → 70 (+27)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less call options, than puts
Call options by funds: $1.23M | Put options by funds: $1.33M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$7.9M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5.78M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$2.89M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.21M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$1.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$2.79M |
| 2 |
Millennium Management
New York
|
-$1.56M |
| 3 |
Renaissance Technologies
New York
|
-$1.31M |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$347K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$286K |
HSTO Hedge Fund Activity: Q2 2017 in Review
70 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2017, worth a combined $57.5M — up 84% from $31.3M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new HSTO positions and 6 closed out — a net gain of 27 holders — while 22 added to existing stakes and 10 trimmed.
The largest buyer was BlackRock, adding an estimated $7.9M. The largest seller was Putnam Investments, exiting entirely with an estimated $2.79M sold.
- 70 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2017, up from 43 in Q1 2017.
- Funds reported $57.5M of Histogen Inc. Common Stock stock for Q2 2017, up 84% quarter-over-quarter.
- 33 funds opened new Histogen Inc. Common Stock positions in Q2 2017 and 6 closed out, a net change of +27 holders.
- The largest Histogen Inc. Common Stock buyer in Q2 2017 was BlackRock, an estimated $7.9M added.
- The largest Histogen Inc. Common Stock seller in Q2 2017 was Putnam Investments, an estimated $2.79M sold.
Based on aggregated 13F filings for Q2 2017.